Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)
Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments provides a complete global revenue summary, including the total global market for preventive vaccines by type for 2015 to 2024 (pediatric total: combinations, hepatitis, haemophilus influenzae type B, measles, mumps and rubella, pneumococcal, poliovirus, varicella, others; adult total: cervical, hepatitis, influenza, pneumococcal, travel and other; total).
The report as well examines the global market for pediatric vaccines by type (Hep, HiB, MMR, combinations, pneumococcal disease, polio, varicella, Others) and by region (U.S., North America/Caribbean, South America, EU, Japan, India, China, rest of world). The report also provides market data on the global revenues for adult vaccines by type (hepatitis, influenza, pneumococcal, travel/other) and by region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) for 2015 to 2024.
Vaccines 2018 examines issues and trends in the vaccine market. The report as well reviews the history and lines of business, strategic alliances, vaccine products, and financial information of market leaders such as GlaxoSmithKline, Merck, Pfizer, and Sanofi Pasteur.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook